Review
doi: 10.1309/WMN8-VTR5-DUGF-X12L.
Current status of HER2 testing: caught between a rock and a hard place
Affiliations
- PMID: 11764067
- DOI: 10.1309/WMN8-VTR5-DUGF-X12L
Item in Clipboard
Review
Current status of HER2 testing: caught between a rock and a hard place
Am J Clin Pathol.
2001 Dec.
No abstract available
Comment on
-
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement.Am J Clin Pathol. 2000 Feb;113(2):251-8. doi: 10.1309/980M-E24R-V19K-595D. Am J Clin Pathol. 2000. PMID: 10664627
-
Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry.Am J Clin Pathol. 2001 Apr;115(4):504-11. doi: 10.1309/VP4W-5C55-7M09-6TX3. Am J Clin Pathol. 2001. PMID: 11293897
-
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis.Am J Clin Pathol. 2001 Jun;115(6):814-22. doi: 10.1309/AJ84-50AK-1X1B-1Q4C. Am J Clin Pathol. 2001. PMID: 11392876
-
Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard.Am J Clin Pathol. 2001 Oct;116(4):495-503. doi: 10.1309/TMUW-G4WB-LXJ2-FUDN. Am J Clin Pathol. 2001. PMID: 11601134
Similar articles
-
Luminal B breast tumors are not HER2 positive.Breast Cancer Res. 2008;10(5):404; author reply 405. doi: 10.1186/bcr2134. Epub 2008 Sep 26. Breast Cancer Res. 2008. PMID: 18831725 Free PMC article. No abstract available.
-
Human epidermal growth factor receptor 2 testing in breast cancer.J Clin Oncol. 2007 Sep 1;25(25):4020; author reply 4021-3. doi: 10.1200/JCO.2007.10.8522. J Clin Oncol. 2007. PMID: 17761991 No abstract available.
-
The clinical evaluation of HER-2 status: which test to use?J Pathol. 2003 Apr;199(4):411-7. doi: 10.1002/path.1354. J Pathol. 2003. PMID: 12635130 Review.
-
Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice.Am J Clin Pathol. 2006 Jan;125(1):155-6. Am J Clin Pathol. 2006. PMID: 16483004 No abstract available.
-
[Standardization of HER2 testing in gastric cancer].Zhonghua Bing Li Xue Za Zhi. 2011 Sep;40(9):645-8. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 22177257 Review. Chinese. No abstract available.
Cited by
-
Targeting HER2-positive breast cancer: advances and future directions.Nat Rev Drug Discov. 2023 Feb;22(2):101-126. doi: 10.1038/s41573-022-00579-0. Epub 2022 Nov 7. Nat Rev Drug Discov. 2023. PMID: 36344672 Free PMC article. Review.
-
Optical fiber-based in vivo quantification of growth factor receptors.Cancer. 2012 Apr 15;118(8):2148-56. doi: 10.1002/cncr.26487. Epub 2011 Aug 25. Cancer. 2012. PMID: 22488668 Free PMC article.
-
Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study.BMC Cancer. 2013 Dec 30;13:615. doi: 10.1186/1471-2407-13-615. BMC Cancer. 2013. PMID: 24377754 Free PMC article.
-
Concomitant detection of HER2 protein and gene alterations by immunohistochemistry (IHC) and silver enhanced in situ hybridization (SISH) identifies HER2 positive breast cancer with and without gene amplification.PLoS One. 2014 Aug 25;9(8):e105961. doi: 10.1371/journal.pone.0105961. eCollection 2014. PLoS One. 2014. PMID: 25153153 Free PMC article.
-
Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arrays.Mol Cell Proteomics. 2013 Sep;12(9):2615-22. doi: 10.1074/mcp.M112.023051. Epub 2013 May 7. Mol Cell Proteomics. 2013. PMID: 23653450 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
